- Home
- BELFB vs VCEL Comparison
BELFB vs VCEL Comparison
Compare BELFB & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BELFB
- VCEL
- Stock Information
- Founded
- BELFB 1949
- VCEL 1989
- Country
- BELFB United States
- VCEL United States
- Employees
- BELFB N/A
- VCEL N/A
- Industry
- BELFB
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BELFB
- VCEL Health Care
- Exchange
- BELFB Nasdaq
- VCEL Nasdaq
- Market Cap
- BELFB 1.8B
- VCEL 2.1B
- IPO Year
- BELFB N/A
- VCEL 1997
- Fundamental
- Price
- BELFB $150.97
- VCEL $31.85
- Analyst Decision
- BELFB Strong Buy
- VCEL Strong Buy
- Analyst Count
- BELFB 4
- VCEL 6
- Target Price
- BELFB $142.25
- VCEL $60.60
- AVG Volume (30 Days)
- BELFB 114.4K
- VCEL 823.8K
- Earning Date
- BELFB 10-22-2025
- VCEL 11-06-2025
- Dividend Yield
- BELFB 0.19%
- VCEL N/A
- EPS Growth
- BELFB N/A
- VCEL 2045.40
- EPS
- BELFB 4.05
- VCEL 0.13
- Revenue
- BELFB $594,034,000.00
- VCEL $249,119,000.00
- Revenue This Year
- BELFB $25.48
- VCEL $18.35
- Revenue Next Year
- BELFB $5.57
- VCEL $22.47
- P/E Ratio
- BELFB $37.23
- VCEL $236.01
- Revenue Growth
- BELFB 6.08
- VCEL 16.13
- 52 Week Low
- BELFB $58.00
- VCEL $29.93
- 52 Week High
- BELFB $152.45
- VCEL $63.00
- Technical
- Relative Strength Index (RSI)
- BELFB 65.36
- VCEL 42.72
- Support Level
- BELFB $144.42
- VCEL $29.93
- Resistance Level
- BELFB $149.41
- VCEL $33.25
- Average True Range (ATR)
- BELFB 4.64
- VCEL 1.75
- MACD
- BELFB -0.06
- VCEL -0.14
- Stochastic Oscillator
- BELFB 93.37
- VCEL 27.91
About BELFB Bel Fuse Inc. Class B
Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.